$30.91
-0.14-0.45%
At Close: -
$30.91
00.00%
After Hours: 4:02 PM EDT
15 minutes delayed
Denali Therapeutics reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Analyze the earnings history of Denali Therapeutics using advanced sorting and filters.
Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $-0.59 | $-0.68 | 13.2 % |
Mar 2024 | 2024-05-07 | $-0.68 | $-0.70 | 2.86 % |
Dec 2023 | 2024-02-27 | $-0.86 | $-0.80 | -7.50 % |
Sep 2023 | 2023-11-07 | $-0.72 | $-0.82 | 12.2 % |
Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
---|---|---|---|---|
Jun 2024 | 2024-08-01 | $0 | $15.04M | -100.0 % |
Mar 2024 | 2024-05-07 | $0 | $14.02M | -100.0 % |
Dec 2023 | 2024-02-27 | $0 | $8.36M | -100.0 % |
Sep 2023 | 2023-11-07 | $1.27M | $10.80M | -88.3 % |
Denali Therapeutics (DNLI) is scheduled to report earnings on November 5, 2024. The last reported earnings were for reported on August 1, 2024 for Q2.
The Actual EPS was $-0.59, which beat the estimate of $-0.68.
The Actual Revenue was $0K, which missed the estimate of $15M.
Browse earnings estimates, EPS, and revenue on all stocks.